Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury.
暂无分享,去创建一个
Yan Cheng | Li Sun | Jing Han | Yan-wei Xu | Hao Liang
[1] D. Praticò,et al. The 12‐15‐lipoxygenase is a modulator of Alzheimer's‐related tau pathology in vivo , 2013, Aging cell.
[2] E. Lo,et al. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase‐dependent semaphorin signaling , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Cristina Viéitez,et al. Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents , 2012, PloS one.
[4] R. Strosznajder,et al. Evaluation of the antioxidative properties of lipoxygenase inhibitors , 2012, Pharmacological reports : PR.
[5] M. Matsuda,et al. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. , 2010, Endocrine journal.
[6] Yan Cheng,et al. 12/15-Lipoxygenase inhibitor baicalein suppresses PPARγ expression and nuclear translocation induced by cerebral ischemia/reperfusion , 2010, Brain Research.
[7] M. Sakharkar,et al. Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of Human , 2009, BMC Genomics.
[8] J. Grotta,et al. Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia , 2009, The Journal of Neuroscience.
[9] G. Weisinger,et al. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. , 2008, American journal of hypertension.
[10] G. Bing,et al. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt , 2008, Journal of Neuroinflammation.
[11] P. Boyle. Diabetes mellitus and macrovascular disease: mechanisms and mediators. , 2007, The American journal of medicine.
[12] D. Feinstein,et al. Peroxisome proliferator‐activated receptor‐γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type‐2 diabetic rodents , 2006, Journal of neurochemistry.
[13] J. Grotta,et al. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARγ) and 15d-prostaglandin J2—Mediated protection of brain after experimental cerebral ischemia in rat , 2006, Brain Research.
[14] J. Roh,et al. Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia , 2006, Brain Research.
[15] T. Herdegen,et al. Activation of cerebral peroxisome proliferator‐activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase‐2 overexpression after focal cerebral ischemia in rats , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] O. Hurtado,et al. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] C. Thiemermann,et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. , 2006, European journal of pharmacology.
[18] G. Landreth,et al. Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia , 2005, Neuroscience.
[19] J. Trojanowski,et al. Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment , 2005, Annals of neurology.
[20] Seung U. Kim,et al. Thrombin-Induced Oxidative Stress Contributes to the Death of Hippocampal Neurons In Vivo: Role of Microglial NADPH Oxidase , 2005, The Journal of Neuroscience.
[21] F. Terro,et al. Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by β-amyloid peptide , 2004, Cell Death and Differentiation.
[22] J. Trojanowski,et al. 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. , 2004, The American journal of pathology.
[23] A. Kannan,et al. A Novel Pathway Involving Progesterone Receptor, 12/15-Lipoxygenase-derived Eicosanoids, and Peroxisome Proliferator-activated Receptor γ Regulates Implantation in Mice* , 2004, Journal of Biological Chemistry.
[24] J. Leers,et al. Activation of PPAR γ in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR γ , 2003 .
[25] U. Dirnagl,et al. Tolerance Against Ischemic Neuronal Injury Can Be Induced by Volatile Anesthetics and Is Inducible NO Synthase Dependent , 2002, Stroke.
[26] S. Dobson,et al. Regulation of VIP and other Neuropeptides by c‐Jun in Sensory Neurons: Implications for the Neuropeptide Response to Axotomy , 1996, The European journal of neuroscience.
[27] J. Vallat,et al. 12-lipoxygenase mRNA expression by cultured neurons. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[28] J. Capone,et al. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Roh,et al. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. , 2006, Brain research.
[30] J. Leers,et al. Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. , 2003, Carcinogenesis.